Clinical Trials Directory

Trials / Completed

CompletedNCT04964726

Dyadic Neurofeedback for Emotion Regulation in Youth With Maternal Adversity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Oklahoma State University Center for Health Sciences · Academic / Other
Sex
Female
Age
14 Years
Healthy volunteers
Accepted

Summary

This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.

Detailed description

The current study will determine the effects of a real-time functional magnetic resonance imaging dyadic neurofeedback (rtfMRI-DNF) protocol that will train mothers with a history of adverse childhood experiences (ACEs) to regulate adolescents' activation in the anterior insular cortex (aIC) - a key brain region for ER. The proposed study will test the efficacy of this protocol to promote healthy ER-related neurodevelopment in adolescents with a maternal history of adversity. The proposed study will use DNF to provide neurofeedback from the adolescent's aIC to the parent as the parent and adolescent engage in an emotion discussion task together. Parents and adolescents (n=10 dyads) will communicate via microphones and noise-canceling headphones while the adolescent is undergoing fMRI scanning. Specific aims of the current study are: (1) to determine the brain response to aIC DNF adolescents, and (2) to determine effects of DNF on parenting behaviors. This study is significant because engaging with parents in DNF can promote positive ER development in adolescents at risk due to the intergenerational effects of ACEs.

Conditions

Interventions

TypeNameDescription
BEHAVIORALReal-time fMRI dyadic neurofeedbackParticipants will attempt to regulate their partner's brain activation in a specified brain region via real-time fMRI neurofeedback.

Timeline

Start date
2021-05-11
Primary completion
2022-12-07
Completion
2022-12-07
First posted
2021-07-16
Last updated
2023-11-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04964726. Inclusion in this directory is not an endorsement.